The Manufacturers Life Insurance Company Has $1.83 Million Stock Holdings in agilon health, inc. (NYSE:AGL)

The Manufacturers Life Insurance Company boosted its stake in agilon health, inc. (NYSE:AGL) by 30.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 279,143 shares of the company’s stock after purchasing an additional 64,528 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.07% of agilon health worth $1,826,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. AQR Capital Management LLC grew its holdings in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Bank of Montreal Can acquired a new position in shares of agilon health during the second quarter valued at about $404,000. Ensign Peak Advisors Inc grew its holdings in shares of agilon health by 43.5% during the second quarter. Ensign Peak Advisors Inc now owns 140,937 shares of the company’s stock valued at $922,000 after buying an additional 42,750 shares during the last quarter. Simplify Asset Management Inc. acquired a new position in shares of agilon health during the second quarter valued at about $659,000. Finally, XTX Topco Ltd acquired a new position in shares of agilon health during the second quarter valued at about $211,000.

agilon health Stock Performance

NYSE AGL opened at $3.32 on Friday. The company’s 50 day moving average is $4.19 and its 200-day moving average is $5.32. The firm has a market cap of $1.37 billion, a P/E ratio of -4.74 and a beta of 0.54. agilon health, inc. has a 12-month low of $2.99 and a 12-month high of $20.37. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. agilon health’s revenue for the quarter was up 38.7% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.04) earnings per share. Sell-side analysts predict that agilon health, inc. will post -0.32 earnings per share for the current year.

Insider Activity at agilon health

In related news, CEO Steven Sell purchased 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 3.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Benchmark reiterated a “buy” rating and set a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft cut their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Royal Bank of Canada restated an “outperform” rating and set a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. Finally, Evercore ISI cut their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $8.03.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.